Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada’s innovative healthcare industry in the previous year. Nominees will be accepted from any of the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, services or healthcare IT sectors, and equal consideration will be given to contributions across any stage of development – from discovery to commercial end markets.
The Bloom Burton Award winner will be chosen from an esteemed panel of judges, all of whom are respected international leaders in healthcare investment, entrepreneurship and journalism.
Nominations for the 2019 Bloom Burton Award are now open. Please read the press release for submission guidelines.
Thursday, September 26, 2019
Four Seasons Hotel
60 Yorkville Avenue
Cocktails 6:00PM | Dinner 7:00PM | Black Tie
Our esteemed panel of judges are respected international leaders in healthcare investment, entrepreneurship and journalism:
Michael Altman, Managing Director, Perceptive Advisors
Karen Bernstein, Co-Founder and Chairman, BioCentury Inc.
Cecilia Gonzalo, Partner, Oberland Capital
Carl Gordon, Partner and Co-Head of Global Private Equity, OrbiMed Advisors
Dennis Purcell, Founder and Senior Advisory, Aisling Capital
Melinda Richter, Global Head of Johnson & Johnson Innovation – JLABS
Mayukh Sukhatme, President, Roivant Pharma
Our three finalists will be celebrated for their incredible contributions to the Canadian healthcare sector. Each of the finalists will receive a $25,000 cash prize, and a single winner will have the honour of being the 2019 Bloom Burton Award recipient.
Tel: (416) 640-7580